Last €15.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
MSTY On Other Exchanges
Symbol
Exchange
EN Paris
Dublin
Frankfurt
As of 12:10 PM 02/10/15 All times are local (Market data is delayed by at least 15 minutes).

mainstay medical internation (MSTY) Snapshot

Open
€15.00
Previous Close
€15.00
Day High
€15.00
Day Low
€15.00
52 Week High
05/2/14 - €22.33
52 Week Low
02/4/15 - €13.90
Market Cap
64.4M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
4.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MAINSTAY MEDICAL INTERNATION (MSTY)

Related News

No related news articles were found.

mainstay medical internation (MSTY) Related Businessweek News

No Related Businessweek News Found

mainstay medical internation (MSTY) Details

Mainstay Medical International plc, together with its subsidiaries, operates as a medical device company in the United States and Australia. It develops ReActiv8, an active implantable medical device for the treatment of people with chronic low back pain, which is in clinical trials. This device primarily serves individuals, families, communities, industries, and governments. The company was formerly known as Mainstay Medical plc and changed its name to Mainstay Medical International plc in March 2014. Mainstay Medical International plc was founded in 2008 and is headquartered in Swords, Ireland.

13 Employees
Last Reported Date: 04/9/14
Founded in 2008

mainstay medical internation (MSTY) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $400.2K
Compensation as of Fiscal Year 2013.

mainstay medical internation (MSTY) Key Developments

Mainstay Medical International plc Submits Application to United States Food and Drug Administration to Begin Clinical Trial of Reactiv

Mainstay Medical International plc has submitted an application to the United States Food and Drug Administration (FDA) to begin a clinical trial of ReActiv8 under an Investigational Device Exemption (IDE). ReActiv8 is an innovative implantable neurostimulation device designed to treat people with disabling Chronic Low Back Pain (CLBP) for whom conventional therapy has not been successful and for whom surgery is not indicated. The goal of ReActiv8 is to reduce pain and disability by addressing the root cause of CLBP in many people by helping to restore control to the muscles that dynamically stabilise the lumbar spine. The clinical trial protocol submitted to the FDA as part of the IDE submission is for an international, multi-centre, prospective randomized controlled trial designed to show safety and efficacy of ReActiv8. The IDE submission includes details of the extensive preclinical and clinical testing conducted on ReActiv8. Upon successful completion of the trial and if the results support it, the company plans to submit an application for a Pre-Market Approval which is the final step to allow start of commercialization in the United States.

Mainstay Medical International plc Presents at The Trout Group 's Annual 1x1 Management Access Event, Jan-12-2015

Mainstay Medical International plc Presents at The Trout Group 's Annual 1x1 Management Access Event, Jan-12-2015 . Venue: The Handlery Hotel, 351 Geary Street, Union Square, San Francisco, California, United States.

Mainstay Medical International plc Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 08:50 AM

Mainstay Medical International plc Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 08:50 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Peter A. Crosby, Chief Executive Officer, President and Executive Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSTY:ID €15.00 EUR 0.00

MSTY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MSTY.
View Industry Companies
 

Industry Analysis

MSTY

Industry Average

Valuation MSTY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAINSTAY MEDICAL INTERNATION, please visit www.mainstay-medical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.